ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för imatinib methanesulfonate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar

Bibliografisk träff 2013-03-05

Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.

Mokhtari D, Al-Amin A, Turpaev K, Li T, Idevall-Hagren O, Li J, Wuttke A, Fred RG, Ravassard P, Scharfmann R, Tengholm A, Welsh N.

Diabetologia · research support, non-u.s. gov't; journal article · DOI 10.1007/s00125-013-2868-2

Bibliografisk träff 2010-12-28

[Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].

de Masson A, Bouvresse S, Clérici T, Mahé E, Saïag P.

Ann Dermatol Venereol · journal article; english abstract; case reports · DOI 10.1016/j.annder.2010.11.009

Bibliografisk träff 2010-11-01

[Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects].

Tsukada Y, Tauchi K, Nakamura M, Kishimoto H, Yoshifuku S, Otagiri N, Sasahara K.

Gan To Kagaku Ryoho · journal article; english abstract; case reports

Bibliografisk träff 2009-07-01

Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.

Terabe F, Kitano M, Kawai M, Kuwahara Y, Hirano T, Arimitsu J, Hagihara K, Shima Y, Narazaki M, Tanaka T, Kawase I, Sano H, Ogata A.

Mod Rheumatol · journal article · DOI 10.1007/s10165-009-0193-x

Bibliografisk träff 2009-06-09

Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.

Bizario JC, Cerri DG, Rodrigues LC, Oliveira GL, Nomizo A, de Araujo DD, Fukuhara PS, Ribeiro JC, de Castro FA, Costa MC.

J Neuroimmunol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jneuroim.2009.05.006

Bibliografisk träff 2009-06-01

[A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].

Aoyama T, Saeki H, Samejima J, Fujii K, Ishikawa Y, Kawamoto M, Fujisawa J, Matsukawa H, Rino Y, Masuda M.

Gan To Kagaku Ryoho · journal article; english abstract; case reports

Bibliografisk träff 2009-03-01

On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: an in vitro study.

Vallières K, Petitclerc E, Laroche G.

Vascul Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.vph.2009.02.003

Bibliografisk träff 2008-12-01

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R.

Clin Breast Cancer · clinical trial, phase ii; research-article; journal article; research support, n.i.h., extramural · DOI 10.3816/cbc.2008.n.062

Bibliografisk träff 2008-05-01

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

Cassier PA, Dufresne A, Arifi S, El Sayadi H, Labidi I, Ray-Coquard I, Tabone S, Méeus P, Ranchère D, Sunyach MP, Decouvelaere AV, Alberti L, Blay JY.

Expert Opin Pharmacother · research support, non-u.s. gov't; review; journal article · DOI 10.1517/14656566.9.7.1211

Bibliografisk träff 2006-11-01

[Neoadjuvant therapy with imatinib mesilate for gastrointestinal stromal tumor of the stomach before subsequent successful surgical resection].

Yamamoto K, Imamura H, Furukawa H, Kishimoto T, Miyazaki Y, Ohshiro R, Tatsuta M, Ohsato H, Fukunaga M, Nakayama T, Fujimi S, Takemoto H, Kondo M, Kamigaki S, Ohta K, Nakata Y.

Gan To Kagaku Ryoho · journal article; english abstract; case reports

Bibliografisk träff 2006-07-01

Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.

Kajita T, Higashi Y, Imamura M, Maida C, Fujii Y, Yamamoto I, Miyamoto E.

J Pharm Pharmacol · journal article · DOI 10.1211/jpp.58.7.0016

Bibliografisk träff 2006-07-01

[A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].

Nakatani K, Tanabe S, Nishimura K, Shimoda T, Azuma M, Katada C, Sasaki T, Higuchi K, Koizumi W, Saigenji K.

Gan To Kagaku Ryoho · journal article; english abstract; case reports

Bibliografisk träff 2006-03-01

Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice.

Kamenz T, Caca K, Blüthner T, Tannapfel A, Mössner J, Wiedmann M.

World J Gastroenterol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3748/wjg.v12.i10.1583

Bibliografisk träff 2005-03-01

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

Holdhoff M, Kreuzer KA, Appelt C, Scholz R, Na IK, Hildebrandt B, Riess H, Jordan A, Schmidt CA, Van Etten RA, Dörken B, le Coutre P.

Blood Cells Mol Dis · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bcmd.2004.11.006

Bibliografisk träff 2004-12-01

[Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].

Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD.

Ai Zheng · journal article; english abstract

Bibliografisk träff 2004-05-01

Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies.

Nadal E, Olavarria E.

Int J Clin Pract · review; journal article · DOI 10.1111/j.1368-5031.2004.00173.x

Bibliografisk träff 2004-04-01

Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.

Houghton PJ, Germain GS, Harwood FC, Schuetz JD, Stewart CF, Buchdunger E, Traxler P.

Cancer Res · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1158/0008-5472.can-03-3344

Bibliografisk träff 2004-01-01

Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.

Matei D, Chang DD, Jeng MH.

Clin Cancer Res · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1158/1078-0432.ccr-0754-03

Bibliografisk träff 2004-01-01

Spotlight on imatinib mesylate in chronic myeloid leukemia.

Curran MP, Croom KF, Goa KL.

BioDrugs · review; journal article · DOI 10.2165/00063030-200418030-00009

Bibliografisk träff 2004-01-01

Use and limitations of imatinib mesylate (Glivec), a selective inhibitor of the tyrosine kinase Abl transcript in the treatment of chronic myeloid leukaemia.

Knight GW, McLellan D.

Br J Biomed Sci · review; journal article · DOI 10.1080/09674845.2004.11732653

Bibliografisk träff 2003-09-15

Interaction of imatinib mesilate with human P-glycoprotein.

Hamada A, Miyano H, Watanabe H, Saito H.

J Pharmacol Exp Ther · journal article · DOI 10.1124/jpet.103.055574

Bibliografisk träff 2003-03-01

[A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].

Fujisawa S, Yano K, Kobayashi M.

Gan To Kagaku Ryoho · journal article; english abstract; case reports

Bibliografisk träff 2003-02-01

[Preclinical and clinical profile of imatinib mesilate, a potent protein-tyrosine kinase inhibitor for CML therapy].

Toga W, Kondo M, Tokoro A.

Nihon Yakurigaku Zasshi · review; journal article; english abstract · DOI 10.1254/fpj.121.119

Bibliografisk träff 2002-05-01

Treatment of hypereosinophilic syndrome with imatinib mesilate.

Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH.

Lancet · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article; case reports · DOI 10.1016/s0140-6736(02)08505-7